Trial intelligence / Profile preview

Liposomal bupivacaine vs ropivacaine for analgesia after hemorrhoidectomy

ChiCTR2300075276Phase 4Recruiting

Sponsor
Nanning Second People's Hospital
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Nanning Second People's Hospital. Primary endpoint: Resting NRS pain score. Started Sep 2023; status: recruiting.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2300075276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300075276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call